与capecitabine相关的不良药物事件:基于FAERS数据库的现实世界药监测研究
Rongqiang Liu1, Yukai Chen2, Shi-Nan Wu3
1Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Therapeutic advances in drug safety
|December 23, 2024
概括
这项研究使用FAERS数据分析了capecitabine的不良反应 (AE),识别了肠道阻塞等罕见事件,并提高了患者的安全性. 研究结果为这种广泛使用的癌症药物指导了临床实践.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 皮他是一种5-甲前药物,用于治疗转移性乳腺癌,结肠直肠癌和胃癌.
- 了解capecitabine的不良反应 (AE) 对临床实践至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 是药物安全的关键数据来源.
研究的目的:
- 使用FAERS数据全面分析与capecitabine相关的副作用.
- 为了识别记录和潜在的罕见不良反应.
- 为了提高对capecitabine安全性概况的理解,以提供临床指导.
主要方法:
- 从FAERS (2004-2023) 收集的capecitabine AEs. 这是一个很好的例子.
- 使用监管活动医学词典 (MedDRA) 标准化的AE分类 26.0.0.
- 采用四种统计方法 (PRR,ROR,BNN,JMA) 来检测不良事件信号,需要在所有四个方面达成共识才能确认.
主要成果:
- 在27个系统器官类别 (SOC) 中分析了45 011个与capecitabine相关的副作用.
- 确定了未在产品标签上列出的AE的重要信号,包括肠道阻塞,穿透性大动脉,以及非肝门高血压.
- 超过40%的副作用发生在治疗的前30天内.
结论:
- FAERS数据分析显示了以前未报告的对capecitabine的不良反应.
- 这些发现有助于更全面地了解capecitabine的安全性.
- 这项研究有助于减轻患者的风险,并在临床环境中优化capecitabine的使用.
相关概念视频
Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Antiepileptic Drugs: Potassium Channel Activators
143
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
143
Factors Influencing Drug Absorption: Disease States and Pharmacology
428
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
428
Factors Influencing Drug Absorption: Pharmaceutical Parameters
114
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
114
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K


